Start your application for this job today
Apply NowStart your application for this job today
Apply NowRRxCo is partnered with a UK-based business established in 2010 focusing on antibody, protein and peptide drug conjugate medicines and technology. The bioconjugation team was formed in 2011 and moved into a state-of-the-art facility in 2018. The facility has been built for containment; with the safety of their people and the environment in mind, and bespoke laboratories have been designed specifically to accommodate highly potent bioconjugations.
Antibody Drug Conjugates combine the cell and tissue specificity of monoclonal antibodies with the cell-killing potential of highly potent small molecules and represent one of the fastest-growing sectors in the oncology field.
Key Notes
Summary
The QC Manager is responsible for managing and leading the QC department at Deeside. This includes personnel, equipment and facilities in the cGMP quality control function/laboratory to support the contract manufacture of parenteral protein-drug conjugate drug substances for pre-clinical, clinical and commercial use. This comprises testing of raw materials, products, process intermediates, stability and environmental samples using a variety of chemical, biochemical and microbiological methods. The manager is responsible for ensuring a state of continuous cGMP compliance and audit readiness within the QC laboratory. Alongside this and of paramount importance the manager is responsible for ensuring appropriate health and safety systems are in place for handling hazardous/toxic analytes. This is also a client-facing role that is essential to the efficient and timely delivery of multiple projects in parallel for a range of pharma clients from small biotech to large pharma, with project scope varying from quick turnarounds to strategic partnerships lasting over several years.
Deliverables
Profile of Individual